2002
Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation today announced that Thomas J. Linnemeier, M.D., FACC, senior vice president, new ventures and chief medical officer, Vascular...
Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that the company has launched the HI-TORQUE BALANCE...
Largest Study to Date, DELIVER II Will Evaluate Clinical Benefit of ACHIEVE Stent in High-Risk Patients Indianapolis, Ind. and Brussels - Guidant Corporation (NYSE and PCX: GDT), a world leader in...
Only Approved Technology to Treat Both Sudden Cardiac Death and Heart Failure; Guidant to Hold Webcast Conference Call Today Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and...
Guidant to Participate in the Deutsche Bank Securities 27th Annual Healthcare Conference
Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate in the Deutsche Bank...